Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Share Repurchase Authorization Limit

Share Repurchase Authorization Limit at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$16.9M+104%
Balchem logo
BalchemBCPC
4M—
SMP
The Simply Good Foods CompanySMPL
$182.5M+155%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's share repurchase authorization limit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's share repurchase authorization limit?
USANA Health Sciences (USNA) reported share repurchase authorization limit of $33.97M in Q1 2026.
How has USANA Health Sciences's share repurchase authorization limit changed year-over-year?
USANA Health Sciences's share repurchase authorization limit decreased by 31.1% year-over-year, from $49.32M to $33.97M.
What does share repurchase authorization limit mean?
This represents the total dollar value or share count that the board of directors has authorized the company to spend on repurchasing its own common stock from the open market. It serves as a signal of management's confidence in the company's valuation and its commitment to returning capital to shareholders. This limit is an authorization, not an obligation to spend.